Previous 10 | Next 10 |
Gainers: Pasithea Therapeutics (NASDAQ:KTTA) +257%, Petros Pharmaceuticals (NASDAQ:PTPI) +73%, Gracell Biotechnologies (NASDAQ:GRCL) +64%, iSpecimen (NASDAQ:ISPC) +43%, Qualigen Therapeutics (NASDAQ:QLGN) +33%. Losers: Longeveron (NASDAQ:LGVN) -36%...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Aurinia Pharma (NASDAQ: AUPH ) stock is taking a beating on Monday following a filing with the U.S. Securities and Exchange Commission (SEC) on Friday. Source: Bukhta Yurii / Shutterstock.com Let’s jump...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Rivian (NASDAQ: RIVN ) stock is in the news today thanks to talk from Outdoorsy about a potential deal for electric vehicles (EVs). Source: Miro Vrlik Photography / Shutterstock.com Let’s take a look ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips PainReform (NASDAQ: PRFX ) stock is on the move Monday with heavy trading despite a lack of news coming from the medical device company. Source: Shutterstock Instead, it looks like traders on social media ha...
Astra Space (NASDAQ:ASTR) +35% after successful commercial orbital launch iSpecimen (NASDAQ:ISPC) +26% selected by U.S. Government and private researchers to supply critical human biospecimens for advanced phase of COVID-19 research PainReform (NASDAQ:PRFX) +19%. Vonage Holding...
Gainers:Greenland Technologies Holding (NASDAQ:GTEC) +72%. Longeveron LGVN +51%. Aurora Innovation AUR +30%. UWM Holdings Corporation UWMC +16%. PainReform (NASDAQ:PRFX) +16%. Losers: Connect Biopharma Holdings CNTB -56%. ReTo Eco-Solutions (NASDAQ:RETO) -42%. F...
PainReform (NASDAQ:PRFX): Q3 Net Loss of %5.5M Cash and cash equivalents of $18.4M Shares -1.57% PM. Press Release For further details see: PainReform reports Q3 results
Reports continued progress towards commencing Phase 3 clinical trials Announces Selection of Pharmaceutics International, Inc . as U.S. Manufacturer of PRF-110 for Upcoming Phase 3 Trial TEL AVIV, Israel, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Pain...
TEL AVIV, Israel, Oct. 14, 2021 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announced that Ilan Hadar, Chief Executive Officer of Pai...
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...
News, Short Squeeze, Breakout and More Instantly...
TEL AVIV, Israel, July 24, 2024 (GLOBE NEWSWIRE) -- PainReform Ltd . (Nasdaq: PRFX) (" PainReform " or the " Company "), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announced it has filed a patent coveri...
TEL AVIV, Israel, June 26, 2024 (GLOBE NEWSWIRE) -- PainReform Ltd . (Nasdaq: PRFX) (" PainReform " or the " Company "), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announced a major milestone on the way to regi...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) rose 3.5% to $129.61 on volume of 255,610,868 shares Longeveron Inc. (LGVN) rose 48.6% to $2.69 on volume of 190,987,878 shares PROSHARES TRUST (SQQQ) fell 1.6% to $8.54 on volume of 116,711,722 shares Tesl...